BIB - ProShares Ultra Nasdaq Biotechnology
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
61.73
+0.27 (+0.44%)
As of 10:00AM EST. Market open.
Stock chart is not supported by your current browser
| Previous Close | 61.46 |
| Open | 61.47 |
| Bid | 61.79 x 800 |
| Ask | 61.88 x 800 |
| Day's Range | 61.28 - 62.02 |
| 52 Week Range | 36.05 - 62.37 |
| Volume | 28,453 |
| Avg. Volume | 133,582 |
| Net Assets | 200.77M |
| NAV | 61.40 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Daily Total Return | 44.78% |
| Beta (3Y Monthly) | 2.64 |
| Expense Ratio (net) | 0.95% |
| Inception Date | 2010-04-06 |
- Investopedia
BIB Versus LABU: Comparing Leveraged Biotech ETFs
Read a comparison of BIB and LABU and a description of the characteristics and historical performance of these leveraged biotech ETFs.
- Zacks
Biotech ETFs in Focus on String of Q1 Earnings Beats
Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.
- Zacks
Will Biotech ETFs Continue to Rally in Q1 Earnings?
Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .
